Colorectal Cancer Therapeutics Market: Global Industry Analysis and Forecast,
2014 – 2020Persistence Market ResearchColorectal Cancer Therapeutics Market:
Global Industry Analysis and Forecast, 2014 2020Persistence Market Research1Colorectal Cancer Therapeutics Market: Global Industry Analysis and Forecast,
2014 – 2020Persistence Market Research Released New Market Report on “Colorectal Cancer
Therapeutics Market: Global Industry Analysis and Forecast, 2014 – 2020”.
Colorectal cancer is a malignant tumor on the inner wall of the large intestine. This is due to the
abnormal growth of cells which have the ability to invade or spread to other parts of the body.
The common causes of colorectal cancer are inflammatory bowel disease and genetic
inheritance. The common symptoms of colorectal cancer include fatigue, diarrhea or
constipation, shortness of breath, weakness, change in bowel habits, red or dark blood in stool,
cramps, narrow stools, weight loss, abdominal pain, and bloating. These symptoms may
develop several years after the formation of the tumor. Various stages for colorectal cancer are:
stage 0, cancer in very early stages present in the innermost layer of the intestine; stage I,
cancer present in the inner layers of colon; stage II, cancer spreads through muscle wall of
colon; stage III, cancer spreads to lymph nodes, stage IV, cancer spreads to other organs.
Some of the drugs in the pipeline for colorectal cancer therapeutics are Lonsurf, CYRAMZA
(ramucirumab), TS-1/Teysuno, CPP-1X (eflornithine hydrochloride), MelCancerVac, Xilonix, and
Nintedanib. There are various medications such as chemotherapy drugs, immunotherapy, and
leucovorin (chemoprotectant) that can be used to treat colorectal cancer. Chemotherapy drugs
for the treatment of colorectal cancer include antimetabolities such as fluorouracil and
capecitabine. Monoclonal antibodies used in immunotherapy as part of the treatment of